CD163 and acute lymphoblastic leukemia: The addition of ALL-derived CM during M1 differentiation induced an average 4-fold increase in the proportion of CD14+ CD163+ cells, a phenotype usually associated with M2 features in MØs [29] (Figure 3A,B).